19 -

19 - Goto K, Sekine I, Nishiwaki Y et al. Multi-institutional phase II trial of irinotecan, cisplatin, and etoposide for sensitive relapsed small-cell lung cancer. Br J Cancer 2004; 91(4):659-665.